Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 22.51
-1.06 (-4.50%)
Jun 2, 2026, 3:00 PM CST
SHA:688639 Market Cap
SHA:688639 has a market cap or net worth of 5.61 billion as of June 2, 2026. Its market cap has decreased by -22.60% in one year.
Market Cap
5.61B
Enterprise Value
7.52B
Revenue
2.95B
Ranking
n/a
PE Ratio
45.21
Stock Price
22.51
Market Cap Chart
Since April 22, 2021, SHA:688639's market cap has increased from 3.81B to 5.61B, an increase of 47.46%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 5.61B | -30.91% |
| Dec 31, 2025 | 8.13B | 10.70% |
| Dec 31, 2024 | 7.34B | -62.99% |
| Dec 29, 2023 | 19.83B | 17.86% |
| Dec 30, 2022 | 16.83B | 20.56% |
| Dec 31, 2021 | 13.96B | 266.67% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 6.47B |
| Jiangsu Aidea Pharmaceutical Group | 6.30B |
| Wuhan Keqian Biology Co.,Ltd | 6.16B |
| Chengdu Kanghua Biological Products | 6.12B |
| Novogene | 5.87B |
| Shanghai OPM Biosciences | 5.74B |
| Shenzhen Weiguang Biological Products | 5.67B |
| Hangzhou Biotest Biotech | 5.57B |